Axsome Therapeutics Inc.
(AXSM)
undefined
undefined%
At close: undefined
86.45
-0.03%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 270.60M | 50.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 26.07M | 5.20M | 1.16M | 77.72K | 37.33K | 48.94K | 42.56K | 20.48K | 3.54K | n/a | n/a |
| Gross Profit | 244.53M | 44.84M | -1.16M | -77.72K | -37.33K | -48.94K | -42.56K | -20.48K | -3.54K | n/a | n/a |
| Operating Income | -231.82M | -176.50M | -124.71M | -99.14M | -67.25M | -32.85M | -27.16M | -27.54M | -9.20M | -5.67M | -1.84M |
| Interest Income | n/a | 7.33M | 5.70M | 2.57M | 1.24M | n/a | n/a | n/a | 914.95K | 2.23M | n/a |
| Pretax Income | -238.28M | -187.13M | -130.40M | -102.90M | -68.35M | -30.97M | -28.94M | -27.20M | -10.56M | -6.00M | -2.17M |
| Net Income | -239.24M | -197.77M | -134.94M | -105.39M | -69.69M | -30.97M | -28.94M | -27.20M | -10.56M | -6.00M | -2.17M |
| Selling & General & Admin | 323.12M | 159.25M | 66.65M | 28.90M | 13.60M | 9.35M | 7.21M | 6.34M | 2.42M | 1.39M | 304.18K |
| Research & Development | 97.94M | 57.95M | 58.06M | 70.24M | 53.65M | 23.50M | 19.96M | 21.20M | 6.78M | 4.28M | 1.54M |
| Other Expenses | 55.29M | 4.14M | n/a | -53.58K | -139.45K | 217.42K | 207.11K | 474.28K | n/a | -184.14K | n/a |
| Operating Expenses | 476.36M | 221.34M | 124.71M | 99.09M | 67.11M | 32.63M | 26.96M | 27.07M | 9.20M | 5.49M | 1.84M |
| Interest Expense | 6.45M | 7.33M | 5.70M | 2.57M | 1.24M | 1.13M | 1.34M | 132.42K | 914.95K | 2.23M | 327.19K |
| Selling & Marketing Expenses | 100.30M | 35.30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 502.43M | 226.54M | 124.71M | 99.09M | 67.11M | 32.63M | 26.96M | 27.07M | 9.20M | 5.49M | 1.84M |
| Income Tax | 960.00K | 10.63M | 4.54M | 2.49M | 1.34M | 3.01M | 1.30M | 586.22K | 1.36M | -2.42M | -1.84M |
| Shares Outstanding (Basic) | 45.43M | 40.66M | 37.62M | 37.21M | 34.02M | 26.88M | 22.76M | 19.15M | 11.95M | 12.72M | 12.72M |
| Shares Outstanding (Diluted) | 45.43M | 40.66M | 37.62M | 37.21M | 34.02M | 26.88M | 22.76M | 19.15M | 11.95M | 12.72M | 12.72M |
| EPS (Basic) | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 | -0.17 |
| EPS (Diluted) | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 | -1.27 | -1.42 | -0.88 | -0.47 | -0.17 |
| EBITDA | -224.99M | -174.23M | -123.55M | -99.06M | -67.21M | -32.58M | -27.77M | -27.52M | -9.19M | -2.74M | n/a |
| Depreciation & Amortization | 6.83M | 5.56M | 1.16M | 77.72K | 37.33K | 48.94K | 42.56K | 20.48K | 3.54K | 2.93M | 1.84M |